// App-Quantinova.ai

SAT0425 : NOVEL COMPUTER-ASSISTED METHODOLOGY FOR QUANTITATIVE ASSESSMENT OF MRI TREATMENT RESPONSES TO APREMILAST IN PATIENTS WITH PSORIATIC ARTHRITIS

Researchers

Presenter

  • P. Bird

Principal Investigators

  • M. Boesen

  • M. Hinton

  • E. Sanverdi

  • R. Hagoug

  • C. Sabin

  • P. Nakasato

  • B. Guerette

  • O. Kubassova

Medical Centers

  • Optimus Research, Kogarah, New South Wales, Australia

  • Copenhagen University Hospital Bispebjerg-Frederiksberg, Department of Radiology, Copenhagen, Denmark

  • Image Analysis Group (IAG), London, United Kingdom

  • Celgene Corporation, Summit, United States of america

Locations

  • Australia

  • Denmark

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Dermatology

  • Musculoskeletal

Disease

  • Psoriatic arthritis

Biomarkers

  • N/A

Drug/Treatment

  • Apremilast

  • Orphenadrine Citrate

Outcome

  • N/A


Study Design

  • Double Blind/Blinded

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A